The last identified marker in this study is NEFM (NM_005382) where 12 methylated CpG sites were identified within the gene's promotor region in tumor samples, while no CpG sites were found to be methylated in normal, tubular adenoma, and tubulovillous adenoma samples (Tables 2 and 3). The gene discussed is NEFM; the disease is tubular adenoma.